32501 - Headlines

Benchmark Clinical Translation to Advance Safe Differentiation, Gene-Editing and Manufacturing Efficiency to Fast-Track Regulatory Submissions

October 3-4 2023 | Boston, MA

Welcome to the 3rd Annual iPSC Derived-Cell Therapies Summit

Accelerate Clinical Proof of Concept for the Future of Cell Therapy & Regenerative Medicine

As the iPSC field continues to evolve and candidates make their way to the clinic, there has never been a more critical time to unite with your peers and take the lead in shaping the future of iPSC drug development!

Join the 3rd Annual iPSC Derived-Cell Therapies Summit, where the brightest minds and leading experts are uniting to benchmark the current bottlenecks in discovery, translation, and clinical strategy. This year's summit promises to be the largest meeting dedicated solely to iPSC drug development, providing a platform to showcase cutting-edge pre-clinical and brand-new clinical data that are redefining the landscape of cell therapies for oncology and regenerative medicine.

Walk away with a robust understanding of how to ensure the highest quality product covering genetic stability, purified differentiation, and in vivo survivability to secure approvals for your groundbreaking iPSC-derived product. Take home creative approaches and pioneering strategies to elevate your investment appeal, navigate the IND requirements and streamline your clinical pipeline for maximum efficiency and delve into the latest advancements in safety protocols, regulatory compliance, and approval processes.

Mark your calendars and secure your spot at the flagship 3rd Annual iPSC Derived-Cell Therapies Summit!

World-Class Speaker Faculty Includes:

Previously Attending Companies Include:

download (1)
download (2)

''A great opportunity to interact with colleagues and learn how others are dealing with common challenges'' - Senior Director, Translational Science & Development, Astellas Institute for Regenerative Medicine

Our Partners

Other Events in the Series